南都讯 记者宋承翰 发自北京 人社部网站9月30日消息，国务院任免国家工作人员。任命郑哲为国家卫 生健康委员会副主任；免去曹雪涛的国家卫生健康委员会副主任职务。此次调整涉及的人员均有学术背 景，卸任的曹雪涛曾经担任南开大学校长，郑哲此前为国家心血管病中心党委书记，中国医学科学院阜 外医院党委书记。 公开资料显示，郑哲致力于心血管外科临床、科研和教学工作。专长冠心病外科手术、瓣膜成形手术、 胸腔镜微创手术、房颤手术等。 郑哲教授课题组主要从事心血管疾病基础与临床研究。（1）关注于缺血性心脏病、心律失等常见心血 管疾病的发病机制和治疗方法与器械研究。多项房颤治疗新器械实现转化。（2）关注医疗质量评价和 临床结局改善评价，以及流行病学、个体化精准医疗和人工智能等领域的研究。团队组织并创建"中国 心血管外科注册登记研究(CCSR)"，促进协作医院心血管外科质量的全面提升；开展医疗结果评价研 究，提高心血管外科临床疗效，发现不同冠脉搭桥技术，以及他汀、抗血小板药物、β受体阻滞剂等对 手术结局的影响，改写多部指南；郑哲教授主持科技部"863"计划、国家重点研发计划、国家自然科学 基金重点项目等国家和省部级科研项目，研究成 ...

Core Viewpoint - The 2025 Capital International Medical Conference and the China-UK Medical Innovation Summit aim to enhance cooperation in medical research and innovation between China and the UK, highlighting the importance of collaborative efforts in global health governance [1][3]. Group 1: Report Highlights - The report titled "2025 China Hospital Research Impact - Global Health Policy and Clinical Guidelines Twenty-Year Citation Report" is the first specialized analysis of how Chinese hospital research results are cited in international clinical guidelines and health policies [4][5]. - The report covers the period from 2005 to 2024 and utilizes the BMJ Impact Analytics tool to evaluate the real-world impact of selected hospitals' academic outputs on healthcare decisions [4]. - A total of 12,601 research outputs from selected hospitals were cited in health policies and clinical guidelines across over 75 countries, with a total citation count of 34,675 [4]. Group 2: Expert Insights - Experts at the summit emphasized the need for collaboration to address common healthcare challenges, particularly in the context of an aging population [7][9]. - The report's findings are expected to significantly aid core product development in the medical industry, enhancing the international competitiveness of medical devices [6]. - The importance of public database construction and sharing in promoting Sino-UK technological innovation and cooperation was highlighted [9]. Group 3: Future Directions - The China Hospital Association launched a medical technology innovation transformation competition to gather outstanding medical technology innovation projects nationwide, providing comprehensive support for award-winning projects [10]. - The BMJ Group aims to deepen collaboration with Chinese hospitals and institutions, offering precise impact assessment tools and promoting international guideline exchanges and clinical research cooperation [10][11].

Core Viewpoint - The 2025 Capital International Medical Conference emphasizes the importance of international collaboration in medical technology innovation, particularly between China and the UK, to enhance global health outcomes [1][3][5]. Group 1: Conference Highlights - The conference was attended by over 1,500 leaders and experts, including officials from the National Health Commission and the World Health Organization [1][2]. - Keynote speeches focused on the shared vision of health for all and the need for collaborative efforts to tackle global health challenges [3][5]. - The BMJ Group co-hosted a forum to promote Sino-British medical technology cooperation and released a significant report on the impact of Chinese hospital research [3][6]. Group 2: Report Insights - The report titled "2025 China Hospital Research Impact - Global Health Policy and Clinical Guidelines Twenty-Year Citation Report" analyzes the citation of Chinese hospital research in international clinical guidelines and health policies from 2005 to 2024 [6][7]. - It highlights that 12,601 research outputs from selected hospitals were cited by health policies and clinical guidelines in over 75 countries, with a total citation count of 34,675 [6][7]. - The report underscores the growing influence of Chinese medical research on international healthcare standards and practices [7]. Group 3: Opportunities for Collaboration - The forum facilitated discussions on the complementary strengths of China and the UK in medical technology innovation, aiming for deeper and broader cooperation [5][12]. - Experts discussed the importance of public databases and shared resources in enhancing Sino-British scientific collaboration [15]. - The conference also launched a competition for innovative medical technology projects, aiming to build a collaborative and mutually beneficial ecosystem for medical innovation [16].

中国经济网北京9月11日讯(记者郭文培)9月10日，以"智领未来，健康生活"为主题的2025年服贸会健康卫生服务专题创新成果发布暨启动活动在京举行，发 布首都卫生发展科研专项2012—2024年第三批十大成果，启动北京市国家人工智能应用中试基地(医疗领域)建设。 据悉，"首发专项"自2012年设立以来，共优化811项诊断方法和1686项治疗措施，制定或更新诊疗指南98部，159个项目获得国家或省部级科学技术奖，技术 转化125项，获得授权专利987项。 本次活动是2025年服贸会健康卫生服务专题的配套活动之一，由北京市卫生健康委牵头、首都会展(集团)有限公司承办，中国医院协会为学术支持单位。 第三批十大成果分别是：抗精神病药物个体化优选治疗方案的构建与推广应用，研究者为北京大学第六医院岳伟华团队；难治性慢性鼻窦炎精准诊疗体系的 构建与应用，研究者为首都医科大学附属北京同仁医院王成硕团队；先天性耳廓畸形的早期干预及系统化治疗体系的构建，研究者为中国医学科学院整形外 科医院蒋海越团队；出生缺陷精准防控突破——构建母胎一体化防治技术体系，研究者为首都医科大学附属北京安贞医院何怡华团队；胎盘植入风险评估和 分层管理体 ...

Group 1 - Australia has set new records in terms of exhibition area and number of exhibitors as the guest country at the current service trade fair, highlighting its emphasis on the Chinese market and opportunities [1][2] - The Australian pavilion at the fair is the largest ever, showcasing a diverse range of industries including higher education, financial services, and tourism, as well as notable brands in food, health products, and wine [2] - The event aims to facilitate deep connections between Australian enterprises and Chinese partners, with 15 memorandums of understanding signed, indicating significant opportunities in bilateral service trade [3] Group 2 - The current global trade environment is complex, necessitating transformation and innovation among enterprises to remain competitive, as reflected in the diverse participation of Australian companies at the fair [4] - The focus on high-tech sectors and collaboration in medical research and technology commercialization is emphasized, with notable participation from a Nobel laureate, showcasing the depth of cooperation between Australia and China [5] - The China-Australia Free Trade Agreement (ChAFTA) has significantly boosted bilateral trade, with ongoing efforts to enhance service trade liberalization and address the needs of enterprises in future negotiations [6]

Core Viewpoint - Australia, as the guest country at the current service trade fair, has set new records in exhibition area and number of exhibitors, highlighting its emphasis on the Chinese market and opportunities [1] Group 1: Trade Relations - China has been Australia's largest trading partner, export market, and import source for 16 consecutive years, indicating the importance of this relationship [1] - The Australia-China Free Trade Agreement (ChAFTA) has significantly promoted bilateral trade prosperity, with a focus on high-quality implementation and review of the agreement [12] Group 2: Exhibition Highlights - The Australian pavilion at the trade fair is the largest ever, showcasing a diverse range of industries including higher education, financial services, and tourism, as well as notable brands in food, health products, and wine [4] - The participation of a strong Chinese government delegation is expected to facilitate connections between Australian exhibitors and key Chinese partners [6] Group 3: Future Opportunities - There is a strong expectation for deep engagement in the service trade sector, with the potential for mutual benefits and significant opportunities [6] - The focus on renewable energy, green economy transformation, and innovative business models reflects the evolving landscape of trade and cooperation [8] Group 4: Areas for Cooperation - Key areas for deepening cooperation include medical research, technology commercialization, and sustainable agricultural practices, with notable Australian enterprises already engaged in these sectors [9] - The need for government to listen to the real demands of businesses is emphasized, as this will guide future negotiations and opportunities [12]

Core Viewpoint - The Fourth China (Macau) International High-Quality Consumption Expo and Hengqin World Bay Area Forum will focus on the theme of "Health New Ecology, Bay Area Common Future," emphasizing the importance of the health industry in economic cooperation between Hengqin and Macau [1][4]. Group 1: Event Overview - The event will take place from September 3 to 7, featuring a health-themed forum on September 6 at the Venetian Macao [1]. - The forum aims to provide a platform for cross-border communication on policy innovation, technological breakthroughs, and collaboration in the health sector [1][4]. Group 2: Key Discussions - The forum will include discussions on Macau's regulatory framework for promoting traditional Chinese medicine products in international markets [3]. - Innovations in frontier medicine and technology will be highlighted, with presentations on cell technology, tissue regeneration, and brain disease repair [3]. - A roundtable will focus on cross-border practices, exploring the integration of medical research resources between Guangdong and Macau [3][4]. Group 3: Industry Collaboration - The forum aims to explore pathways for building a new health ecology through institutional, research, and industrial collaboration between Guangdong and Macau [4]. - It will serve as a new observation window for cross-border medical and industrial cooperation [4].

Core Insights - The article highlights a significant breakthrough in clinical brain-machine interface technology, specifically for precise tumor boundary localization during surgery, marking the first global clinical trial of its kind [1][2]. Group 1: Technology Development - The clinical trial was conducted by the Aerospace Information Research Institute and the First Affiliated Hospital of Harbin Medical University, utilizing the NeuroDepth microelectrode developed by the Aerospace Institute [1]. - The technology includes a high-throughput neural signal detection device (AIRCAS-128) that synchronously collects and analyzes vast amounts of neural signals, converting raw signals into precise "lesion navigation" data for real-time tumor boundary assessment [1]. Group 2: Clinical Application - This technology overcomes the limitations of traditional neural electrodes, which could only detect signals from the brain's surface and shallow layers, allowing for detection across all brain regions, including deep brain areas [2]. - It can also simultaneously detect chemical signals such as dopamine and glutamate, providing comprehensive data to differentiate between tumor and normal tissue, which is crucial for accurate surgical planning and execution [2].

Core Viewpoint - The successful completion of the clinical trial for a brain-machine interface (BMI) technology developed by the Chinese Academy of Sciences marks a significant breakthrough in the precise localization of brain tumor boundaries during surgery, showcasing the potential for improved surgical outcomes and patient quality of life [3][4][6]. Group 1: Clinical Trial and Technology - The clinical trial involved the use of an implanted microelectrode array for precise tumor boundary localization during surgery, representing the first application of BMI technology in this context globally [3][4]. - The technology includes the NeuroDepth microelectrode and the AIRCAS-128 device, which allows for high-resolution, real-time detection of neural signals, enabling accurate identification of tumor boundaries [6][7]. - The microelectrode can detect neural activity at a spatial resolution of 15 micrometers and can be used throughout the entire brain, overcoming limitations of traditional methods [6][7]. Group 2: Clinical Implications - The BMI technology provides real-time navigation for neurosurgery, potentially increasing the rate of successful tumor removals while preserving healthy brain tissue [4][5]. - The clinical trial demonstrated successful tumor removal in a patient with glioma, leading to improved postoperative outcomes without new neurological deficits [7]. - The technology addresses the need for dynamic intraoperative identification of tumor boundaries, which has been a challenge in neurosurgery [7][8]. Group 3: Future Applications and Development - The Chinese Academy of Sciences plans to expand the application of BMI technology to areas such as sensory restoration for visually and hearing-impaired patients, as well as rehabilitation for stroke and hydrocephalus patients [9]. - The successful trial is seen as a critical step towards the clinical translation and industrialization of BMI technology, with ongoing collaboration expected to enhance technological advancements and clinical applications [8][9].

Core Insights - The National Development and Reform Commission has officially approved the establishment of the "National Artificial Intelligence Application Pilot Base (Clinical Medical Research Direction)" to be undertaken by Zhongshan Hospital [1] - The base aims to focus on clinical research, address industry pain points, and build an ecological benchmark, creating an innovative support platform covering the entire chain from R&D to application [1] Group 1: Infrastructure and Capabilities - The base will construct a domestic computing power support platform, ensuring privacy data remains within the domain, which is crucial for secure and efficient data processing and model training [1] - A comprehensive model service system will be developed, utilizing domestically controllable foundational large models and AI frameworks, covering model engineering, agent engineering, and AI asset management [1] Group 2: Application and Impact - The base will target areas such as medical research, enhancement of intelligent diagnostic capabilities, development of smart medical devices, and research on intelligent medical robots, with plans to implement at least 49 distinctive application scenarios [1] - More than 10 supporting standards and specifications will be published, significantly improving diagnostic accuracy and efficiency, allowing medical personnel to focus on complex cases and treatment optimization [1] - Patients will benefit from more efficient diagnostic processes, personalized treatment plans, and optimized services throughout the entire process from pre-consultation to post-operative follow-up [1]